ArticleCancer reports (Hoboken, N.J.)2025
Prevalence and Associated Factors of Hypercalcemia of Malignancy Among Advanced Cancer Patients Attending Palliative Care Unit of a Tertiary Care Hospital in Bangladesh.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundHypercalcemia is a common complication of advanced malignancy and a palliative care emergency. Its incidence increases in the later stages of the disease and is linked to a poor prognosis. Understanding the prevalence, clinical characteristics, and factors associated with malignancy-related hypercalcemia is crucial for developing targeted interventions and enhancing overall palliative care for advanced cancer patients.
aimThis study aims to provide baseline data on the prevalence, clinical presentation, and factors associated with hypercalcemia among advanced cancer patients receiving palliative care in Bangladesh.
methodsThis cross-sectional study was conducted among 155 advanced cancer patients admitted to the Department of Palliative Medicine, Bangabandhu Sheikh Mujib Medical University, Bangladesh, from June to December 2023. Data were collected through patient histories, physical examinations, and laboratory analyses. Statistical tests, including Chi-square test, Fisher's exact test, and Mann Whitney U test (for skewed data), were used to examine associations between socio-demographic and disease-related variables and serum calcium levels. Binary logistic regression was applied to identify factors affecting hypercalcemia.
resultAmong the participants, 20% had hypercalcemia, with 51.6% experiencing mild, 25.8% severe, and 22.6% moderate hypercalcemia. Head-and-neck cancers (12.9%) and gastrointestinal malignancies (22.6%) were more common in hypercalcemic patients. Lethargy, polyuria, polydipsia, constipation and dehydration were more prevalent among hypercalcemic participants. However, lethargy, nausea, confusion, drowsiness, abdominal pain, and constipation, which are typically more common in hypercalcemic patients, were more frequent in the normocalcemic group. Binary logistic regression analysis revealed that age between 41 and 65 years, male sex, poor performance status, and a short disease duration (up to 6 months) were significant risk factors for developing hypercalcemia among cancer patients.
conclusionMalignant hypercalcemia affected nearly one-fourth of patients with advanced malignancy in our study setting. It is important for healthcare providers to be aware of the common symptoms of hypercalcemia and to regularly monitor calcium levels in advanced cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.